Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Gains from Sales and Divestitures (2018 - 2020)

Updated

Moderna's Gains from Sales and Divestitures was -$61.71 million in Q4 2020, compared with $70,000 a year earlier.

Analysis

Moderna (MRNA) Gains from Sales and Divestitures (2018 - 2020) Analysis & Trends

For FY2020, Gains from Sales and Divestitures at Moderna came in at -$62 million.

  • In earlier years, Gains from Sales and Divestitures was -$891,000 in FY2018.
  • The Q4 2020 figure marks the lowest quarterly Gains from Sales and Divestitures in data going back to Q4 2018.
  • Per Business Quant data, MRNA's Gains from Sales and Divestitures in the three quarters before Q4 2020 was -$61,000 (Q3 2020), -$89,000 (Q2 2020) and -$137,000 (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -61.71 Mn
Sep 30, 2020 -61,000.00
Jun 30, 2020 -89,000.00
Mar 31, 2020 -137,000.00
Dec 31, 2019 70,000.00
Sep 30, 2019 -56,000.00
Jun 30, 2019 5,000.00
Mar 31, 2019 -19,000.00
Dec 31, 2018 -891,000.00
API Access

Moderna Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MRNA&period=max&api_key=YOUR_API_KEY